An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.
Related Posts
Hamas releases new hostage video, includes American captive
Hamas released new footage of hostages on Saturday
Feeling stuck? How to find or reignite your life’s purpose
If you’re feeling stuck in a rut, there are